Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NFX-179 Gel in Epidermal Nevi
NCT05195762Phase 2Withdrawn
- Start
- Jun 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NFX-179 Gel in epidermal nevus, nevus sebaceus. Planned start Jun 2023; status: withdrawn.
02
Drugs
NFX-179 Gel
03
Conditions
epidermal nevusnevus sebaceus
Beyond the preview
Go deeper on NCT05195762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05195762.